163 related articles for article (PubMed ID: 18036394)
1. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
3. An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
Pal SK; Blazer K; Weitzel J; Somlo G
Breast Cancer Res Treat; 2009 May; 115(1):1-5. PubMed ID: 18500673
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
Papi L; Palli D; Masi L; Putignano AL; Congregati C; Zanna I; Marini F; Giusti F; Luzi E; Tonelli F; Genuardi M; Brandi ML; Falchetti A
Cancer Genet Cytogenet; 2009 Nov; 195(1):75-9. PubMed ID: 19837273
[TBL] [Abstract][Full Text] [Related]
5. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
Cho JH; Bang S; Park SW; Chung JB; Song SY
Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
9. BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report.
Lavie O; Ben-Arie A; Pilip A; Rennert G; Cohen Y; Feiner B; Auslnader R
Gynecol Oncol; 2005 Nov; 99(2):486-8. PubMed ID: 16051327
[TBL] [Abstract][Full Text] [Related]
10. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
11. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
[TBL] [Abstract][Full Text] [Related]
14. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism.
Perrier ND; Villablanca A; Larsson C; Wong M; Ituarte P; Teh BT; Clark OH
World J Surg; 2002 Aug; 26(8):907-13. PubMed ID: 12016470
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer.
Hu N; Wang C; Han XY; He LJ; Tang ZZ; Giffen C; Emmert-Buck MR; Goldstein AM; Taylor PR
Oncogene; 2004 Jan; 23(3):852-8. PubMed ID: 14647438
[TBL] [Abstract][Full Text] [Related]
16. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasms.
Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):149-63. PubMed ID: 18328987
[TBL] [Abstract][Full Text] [Related]
18. Familial pancreatic cancer: from genes to improved patient care.
Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
[TBL] [Abstract][Full Text] [Related]
19. p27kip1: a new multiple endocrine neoplasia gene?
Marinoni I; Pellegata NS
Neuroendocrinology; 2011; 93(1):19-28. PubMed ID: 20980721
[TBL] [Abstract][Full Text] [Related]
20. Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report.
Fruscalzo A; Damante G; Calcagno A; Di Loreto C; Marchesoni D
Cancer Invest; 2006 Oct; 24(6):611-4. PubMed ID: 16982466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]